Predix Pharmaceuticals Holdings Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 26
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $90M
Latest Deal Amount

Predix Pharmaceuticals Holdings General Information

Description

Operator of a drug development company. The company focuses on the discovery and development of small-molecule drugs that target G-protein coupled receptors (GPCRs) and ion channels, used in the treatment of treating anxiety, Alzheimer's disease, pulmonary arterial hypertension and other diseases.

Contact Information

Formerly Known As
Bio-IT
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
EPIX Pharmaceuticals
Primary Office
  • 4 Maguire Road
  • Lexington, MA 02421
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Predix Pharmaceuticals Holdings Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 16-Aug-2006 $90M 000.00 0000 Completed Clinical Trials - Phase 2
8. IPO 26-Oct-2005 0000 00000 Cancelled Clinical Trials - Phase 2
7. Later Stage VC (Series C) 25-Jan-2005 0000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 09-Aug-2004 000.00 Completed Generating Revenue
5. Later Stage VC (Series A) 22-Aug-2003 00.000 000.00 Completed Product Development
4. Later Stage VC (Series E) 01-Aug-2001 00.00 000.00 00000 Completed Product Development
3. Later Stage VC (Series D) 02-Nov-2000 000 000.00 Completed Product Development
2. Later Stage VC (Series C) 13-May-1999 $11.8M $21.8M 000.00 Completed Generating Revenue
1. Early Stage VC (Series B) 06-Nov-1997 $10M $10M 0000 Completed Generating Revenue
To view Predix Pharmaceuticals Holdings’s complete valuation and funding history, request access »

Predix Pharmaceuticals Holdings Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 000,000,000 00.000000 00 00.00 00.00 00.00 00.000
Series AB 00,000,000 00.000000 00.00 00.00 00.00 0.000
To view Predix Pharmaceuticals Holdings’s complete cap table history, request access »

Predix Pharmaceuticals Holdings Executive Team (3)

Name Title Board Seat Contact Info
Michael Kauffman Ph.D Chief Executive Officer & President
You’re viewing 1 of 3 executive team members. Get the full list »

Predix Pharmaceuticals Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Predix Pharmaceuticals Holdings Former Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
Auckland UniServices Venture Capital Minority 000 0000 000000 0
Boston Millennia Partners Growth/Expansion Minority 000 0000 000000 0
DrKB Life Science Partners Other Minority 000 0000 000000 0
Forward Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »

Predix Pharmaceuticals Holdings Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 00000000 13-Aug-2003 000000000000000000 Other Pharmaceuticals and Biotechnology
To view Predix Pharmaceuticals Holdings’s complete acquisitions history, request access »